Aryeh Capital Management Ltd. Buys Shares of 273,900 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Aryeh Capital Management Ltd. bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 273,900 shares of the company's stock, valued at approximately $10,860,000. Acadia Healthcare makes up approximately 6.5% of Aryeh Capital Management Ltd.'s portfolio, making the stock its 9th biggest position. Aryeh Capital Management Ltd. owned 0.29% of Acadia Healthcare as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ACHC. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after purchasing an additional 76,490 shares in the last quarter. FMR LLC raised its holdings in shares of Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after acquiring an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock worth $126,189,000 after acquiring an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter. Finally, Stephens Investment Management Group LLC raised its stake in Acadia Healthcare by 24.9% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company's stock valued at $58,490,000 after purchasing an additional 294,210 shares during the last quarter.

Analysts Set New Price Targets

ACHC has been the subject of a number of research reports. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. TD Cowen reduced their price target on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Finally, Mizuho dropped their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $50.39.

Acadia Healthcare Trading Up 1.5 %

ACHC stock traded up $0.36 during mid-day trading on Wednesday, hitting $24.16. 2,043,746 shares of the company were exchanged, compared to its average volume of 1,629,843. Acadia Healthcare Company, Inc. has a 12-month low of $20.36 and a 12-month high of $82.41. The firm has a market capitalization of $2.23 billion, a P/E ratio of 7.92, a PEG ratio of 1.46 and a beta of 1.01. The business has a fifty day simple moving average of $26.92 and a 200-day simple moving average of $37.00. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.